PE Tech Report


Like this article?

Sign up to our free newsletter

Terramera closes financing led by Seed 2 Growth Ventures

Seed 2 Growth Ventures (S2G), a Chicago-based venture capital firm has led an investment in Vancouver-based Terramera, Inc. Other key investors in the financing include ACA Investments (affiliate of Sumitomo Corporation), Bold Capital Partners, Renewal Funds and Maumee Ventures.

“Terramera is very proud to be working with S2G Ventures as our lead investor in this recent round of financing,” says Terramera CEO, Karn Manhas. “Terramera develops safer, more effective solutions for public health, sustainable food production, and bee health, by harnessing the power of natural plant defenses with innovative green chemistry. This investment allows us to continue our rapid growth, fund products to get to market, and support Terramera’s advancement as a sustainable technology leader.”

By studying plants that have evolved highly-effective defenses against pests and disease, Terramera has developed proprietary platforms that stabilise and deliver complex plant biochemicals, such as cold-pressed neem and other plant-extracts. (Neem is a tropical evergreen tree native to South Asia. Neem extracts have been used in human health care, hair, skin and dental care, traditional medicine and environmental uses for thousands of years.) Terramera’s Inspirium® Technology increases the efficiency and performance of biological materials, allowing them to perform more efficiently. The result is products that work better than today’s synthetic conventional chemicals at protecting against pests and disease; and in agriculture, products that promote plant health and increase farm yields.

Terramera’s consumer line, Proof, includes the only EPA-registered products that are 100% effective against bed bugs and their eggs. Terramera’s agricultural products, under development, increase sustainability and profitability of conventional farms, and can help farmers profitably transition to organic.

“Biopesticides and biofertilizers, which currently represent a small but growing part of the agriculture inputs market, are the next frontier for sustainable agriculture. One of the key issues holding back quicker adoption has been performance. Terramera has developed a technology that solves that, allowing current biologics to perform more effectively,” says Sanjeev Krishnan, Managing Director, S2G Ventures. “Terramera is uniquely positioned to lead the market with technology and products that are natural, highly-effective and most importantly, more economically beneficial to farmers. S2G Ventures is excited to partner with Terramera and help them scale. It’s a natural fit.”

Like this article? Sign up to our free newsletter